Ascendiant Capital Markets Maintains Buy Rating for Knightscope Raises Per Share Price Target to $4.25
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240501222062/en/
Ascendiant Capital Markets Maintains Buy Rating for Knightscope Raises Per Share Price Target to
Ascendiant has conducted extensive research and analysis stating, “We believe revenues should increase significantly in 2024/25. We have modeled high revenue growth in 2024 (+25%) and 2025 (+20%) and thereafter to scale up significantly which should drive improved margins and profitability.”
Ascendiant is an investment banking and equity research firm focusing on high-growth sectors, with expertise in technology, healthcare, and other emerging industries. It has not received compensation for advisory or investment banking services from the Company in the past 12 months.
“Valuation attractive: We are maintaining our BUY rating but raising our 12-month price target to
Investors, analysts, and members of the media are encouraged to review the research report here.
About
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as “should,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” “proposes” and similar expressions. Forward-looking statements contained in this press release and other communications include, but are not limited to, statements about the Company’s goals, profitability, growth, prospects, reduction of expenses, and outlook. Although
View source version on businesswire.com: https://www.businesswire.com/news/home/20240501222062/en/
Public Relations:
(650) 924-1025
Source: